Neurocrine Biosciences (NBIX) Tops Q3 EPS by 75c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $154.06 -1.19%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.97, $0.75 better than the analyst estimate of $0.22. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $283.04 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside
- SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
